James D. Bangs, PhD, Grant T. Fisher Professor and chair of microbiology and immunology, has received National Institutes of Health (NIH) funding to continue his study of human African trypanosomiasis, also known as sleeping sickness.
At the 2017 Medical Student Research Forum, aspiring physician-scientists showcased 46 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
UB’s Summer Research Fellowship Program, which provides first-year medical students with a personalized experience in research, has been renewed through another five years of funding from the National Institutes of Health.
Anthony A. Campagnari, PhD, senior associate dean for research and graduate education, is exploring the novel use of photodynamic therapy (PDT) as a noninvasive treatment for otitis media (OM) or middle ear infections.
Ira J. Blader, PhD, professor of microbiology and immunology, is using new grant funding to build on prior research aiming to identify how the infection-causing parasite Toxoplasma gondii triggers seizures and other neurological complications in AIDS and cancer patients as well as fetuses.
Aspiring physician-scientists showcased 38 original research projects at the 2016 Medical Student Research Forum. The displays showed work they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
In the fight against infectious disease, University at Buffalo immunologist Michael W. Russell, PhD, professor of microbiology and immunology, advocates a novel alternative to antibiotics and vaccines: directly target the immune system.
At the 2015 Medical Student Research Forum, aspiring physician-scientists showcased 45 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Award-winning participants in the Department of Medicine’s second annual Research Day are studying diverse topics, including disease processes for atrial fibrillation; treatments for leukemia, diabetes and COPD; and the need for cortisol.
Ira Jacob Blader, PhD, associate professor of microbiology and immunology, will build on prior research to identify and explore a key host cell pathway essential for the growth of the infection-causing parasite Toxoplasma gondii.
University at Buffalo scientists will continue nearly three decades of groundbreaking research on a bacterium considered a key cause of the hallmark signs of chronic obstructive pulmonary disease (COPD).
With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.